AVE 0.00% 0.3¢ avecho biotechnology limited

financials have been released, page-40

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    I don't see 6 mil, I see consolidated cash reserves of 2.7 mil.

    Sure cash reservers, but they have more than just cash reserves equalling $6mill. Regardless, POHs costs have been reducing due to key partners paying for research. $2.7mill is plenty for them to survive on as a going concern for the foreseeable future, taking out the capital required to progress Oxy (which they won't be doing until funding is secured anyway).

    Nice to know you look at things with your eyes open. I'll write that tip down.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.